New opportunity called Expanded Access Program for ALS patients in the Northland wdio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wdio.com Daily Mail and Mail on Sunday newspapers.
CELEBRATION, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that it will present at the upcoming Oppenheimer
Special access to childhood brain cancer medicine miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
$20M Funding for DIPG & Other Pediatric Brain Cancer Treatments miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Atara Biotherapeutics, Inc. and Pierre Fabre Laboratories announced that data from the pivotal Phase 3 ALLELE study of tab-cel, approved in the European Union in adults and children two years of age.